An insight into the diagnostic, prognostic, and taxanes resistance of double zinc finger and homeodomain factor

Chemoresistance Diagnosis Expression profile Primary prostate cancer Prognosis Zeb-1

Journal

3 Biotech
ISSN: 2190-572X
Titre abrégé: 3 Biotech
Pays: Germany
ID NLM: 101565857

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 17 01 2023
accepted: 28 01 2024
pmc-release: 01 04 2025
medline: 13 3 2024
pubmed: 13 3 2024
entrez: 13 3 2024
Statut: ppublish

Résumé

Currently, clinical biomarkers are urgently needed to improve patient management to guide personal therapy for cancer. In this study, we investigate the deregulation of The online version contains supplementary material available at 10.1007/s13205-024-03941-8.

Identifiants

DOI: 10.1007/s13205-024-03941-8 PMID: 38476644 PMC: PMC10925581
pubmed: 38476644
doi: 10.1007/s13205-024-03941-8
pii: 3941
pmc: PMC10925581
doi:

Types de publication

Journal Article

Langues

eng

Pagination

106

Informations de copyright

© King Abdulaziz City for Science and Technology 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Déclaration de conflit d'intérêts

Conflict of interestThe authors have no conflicts of interest to declare that are relevant to the content of this article.

Auteurs

Rahma Said (R)

Laboratory of Protein Engineering and Bio-Active Molecules, National Institute of Applied Science and Technology - University of Carthage, Tunis, Tunisia.
Molecular Biology Laboratory, Department of Pathology, Hospital Universitari Vall d'Hebron, Passeig Vall d´Hebron, 119-129, 08035 Barcelona, Spain.
ORCID: 0000-0001-6212-3637

Javier Hernández-Losa (J)

Molecular Biology Laboratory, Department of Pathology, Hospital Universitari Vall d'Hebron, Passeig Vall d´Hebron, 119-129, 08035 Barcelona, Spain.

Rim Jenni (R)

Laboratory of Protein Engineering and Bio-Active Molecules, National Institute of Applied Science and Technology - University of Carthage, Tunis, Tunisia.

Rosa Somoza Lopez de Haro (RSL)

Molecular Biology Laboratory, Department of Pathology, Hospital Universitari Vall d'Hebron, Passeig Vall d´Hebron, 119-129, 08035 Barcelona, Spain.

Teresa Moline (T)

Molecular Biology Laboratory, Department of Pathology, Hospital Universitari Vall d'Hebron, Passeig Vall d´Hebron, 119-129, 08035 Barcelona, Spain.

Skander Zouari (S)

Urology Department, Charles Nicolle Hospital, Tunis, Tunisia.

Ahlem Blel (A)

Pathology Anatomy and Cytology Department, Charles Nicolle Hospital, Tunis, Tunisia.

Soumaya Rammeh (S)

Pathology Anatomy and Cytology Department, Charles Nicolle Hospital, Tunis, Tunisia.

Amine Derouiche (A)

Urology Department, Charles Nicolle Hospital, Tunis, Tunisia.

Slah Ouerhani (S)

Laboratory of Protein Engineering and Bio-Active Molecules, National Institute of Applied Science and Technology - University of Carthage, Tunis, Tunisia.

Classifications MeSH